Men's Health

“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.

"The updated guideline includes numerous new, important recommendations that will enhance the ability of urologists to provide optimal, state-of-the-art care for infertile males,” says Robert E. Brannigan, MD.

"We propose a new classification system, which we believe will provide a more consistent and standardized approach to classification and treatment of PD," says Landon Trost, MD.

“It's been exciting to be on the forefront of new technology and new implants to help men regain their sexual function and empower them,” says Dr. Helen L. Bernie, DO, MPH.

“This is a great opportunity for public outreach and re-education on the common misconceptions surrounding vasectomy,” says Catherine S. Nam, MD.

“One thing is we’re trying to create an atmosphere in the center whereby men feel at ease, they're comfortable talking to their provider who is specialized in this field,” says Ramy Abou Ghayda, MD, MPH, MBA.

A decision on the NDS for testosterone undecanoate is expected in Q2 of 2025.

"Compared to the prior years, we found that there was a 150% increase in new vasectomy consults that were completed, and there was a 160% increase in the number of vasectomies that were done," says Catherine S. Nam, MD.

The study has enrolled 8 patients to assess the safety and efficacy of the device in sealed vasectomy procedures.

“Perhaps it's worth giving them questionnaires like the PHQ-9 or GAD-7 to monitor their mental health status and encourage or ask if they even have support around them,” says Olivia Paulsen.

“However, what direct to consumer does provide is convenience and privacy. Men's health has a huge stigma on it,” says Justin M. Dubin, MD.

"What we saw among over 400 patients [was] that indeed, subcutaneous heparin did not increase the hematoma chance, but it reduced the chance to have venous thrombotic events," says Thairo Pereira, MD.

“The association of lower testosterone concentrations with higher all-cause mortality was present irrespective of luteinizing hormone concentrations, indicating that low testosterone was the main factor," says Bu B. Yeap, MBBS, FRACP, PhD.

Data showed that 87.8% of treated patients and 96.1% of patients who completed the study achieved normal 24-hour mean plasma testosterone values (222 to 800 ng/dL) at 90-day follow-up.

The oral TRT study plans to enroll 20 male patients aged 18 to 49 years who meet the American Urological Association’s criteria for hypogonadism and who have not previously used TRT.

“In addition to the psychological and emotional burden associated with infertility, it's also been growing in incidence,” says Catherine S. Nam, MD.

“So, always going where the point of max curve is gives a much better outcome compared to if you're using any other technique,” says Landon Trost, MD.

The study is set to begin in January 2024.

“Sexual wellness is critical to overall health and happiness. That’s why you see more men and women turning to specialty health clinics for solutions to problems they consider more aesthetic versus medical,” said Mitchell Hollander, MD.

If replicated with further study, the finding potentially expands noninvasive fertility treatment options and may minimize the need for expensive reproductive technology, according to lead author Scott D. Lundy, MD, PhD, of Cleveland Clinic’s Department of Urology.

The inclusion of PAE in the American Urological Association BPH Guidelines offers a non-surgical alternative that can provide long-term relief with minimal downtime and fewer complications, according to the United Urology Group.

Event to raise funds for urologic research, education and innovation.

National MENtion It® campaign explores the impact stress has on men’s sexual and mental well-being.

“A major finding from our study is how multiple sociodemographic, lifestyle, and medical factors influence testosterone levels in men," says Bu B. Yeap, MBBS, FRACP, PhD.

"This landmark registry will facilitate more comprehensive knowledge of treatment and management [of Peyronie's disease] using real-world evidence," said Mohit Khera, MD.

Among patients who did not have a response during the first cycle, 60.8% achieved a response after the fourth.

“We are excited to report that a simple, low-cost intervention can positively [affect] young men’s willingness to engage with their health," says Wade Gutierrez.

“[Collagenase clostridium histolyticum (Xiaflex)] is an incredibly important part of the treatment armamentarium for Peyronie's disease in the US,” says Matthew J. Ziegelmann, MD.

The findings also highlighted the diversity of physicians performing the procedure in regard to background and outcomes.

Investigators found that mitigation methods such as adding a physical barrier or increasing distance could lessen the harmful effects.